Migraine Patch Now Available at Specialty Pharmacies
The first and only patch to provide migraine relief is now available by prescription through specialty pharmacies.
The first and only patch to provide migraine relief is now available by prescription through specialty pharmacies.
Teva’s single-use sumatriptan iontophoretic transdermal system (Zecuity) is indicated for the acute treatment of migraine headaches with or without aura in adults. It is not used to prevent or decrease the number of migraine headaches.
The patch is worn on the upper arm or thigh for a 4-hour period, during which it delivers sumatriptan, the most widely prescribed migraine medication, through the skin.
In a placebo-controlled clinical study, significantly more patients using Zecuity reported no headache pain, nausea, or sensitivity to light or sound 2 hours after patch application.
Because Zecuity can cause heart attack and other heart problems that may lead to death, the patch should not be prescribed for patients with risk factors for heart disease unless a heart exam is conducted and shows no problem.
The most common side effects include pain, tingling, itching, warmth, discomfort, or a change in the skin color where the patch is applied.
To provide migraine education and assistance with Zecuity treatment, Teva is launching Migraine Support Solutions that includes an offer to potentially save patients money on their prescriptions. To contact this program, call 1-855-ZECUITY (1-855-932-8489).
